Low level laser therapy reduces acute lung inflammation in a model of pulmonary and extrapulmonary LPS-induced ARDS-Reference-Cited by-同舟云学术

Low level laser therapy reduces acute lung inflammation in a model of pulmonary and extrapulmonary LPS-induced ARDS

Published:2014-05 Issue: Volume:134 Page:57-63
ISSN:1011-1344
Container-title:Journal of Photochemistry and Photobiology B: Biology
language:en
Short-container-title:Journal of Photochemistry and Photobiology B: Biology

Author:

Oliveira Manoel Carneiro,Greiffo Flávia Regina,Rigonato-Oliveira Nicole Cristine,Custódio Ricardo Wesley Alberca,Silva Vanessa Roza,Damaceno-Rodrigues Nilsa Regina,Almeida Francine Maria,Albertini Regiane,Lopes-Martins Rodrigo Álvaro B.,de Oliveira Luis Vicente Franco,de Carvalho Paulo de Tarso Camillo,Ligeiro de Oliveira Ana Paula,Leal Ernesto César P.,Vieira Rodolfo P.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Biophysics,Radiological and Ultrasound Technology,Radiation

Reference27 articles.

1. Low-level laser therapy induces dose-dependent reduction of TNFα levels in acute inflammation;Aimbire;Photo Laser Surg.,2006

2. Low level laser therapy (LLLT) decreases pulmonary microvascular leakage, neutrophil influx and IL-1β levels in airway and lung from rat subjected to LPS-induced inflammation;Aimbire;Inflammation,2008

3. Neutrophil-derived IL-1b is sufficient for abscess formation in immunity against Staphylococcus aureus in mice;Cho;PLoS Pathogens,2012

4. Low-level laser therapy restores the oxidative stress balance in acute lung injury induced by gut ischemia and reperfusion;De Lima;Photochem. Photobiol.,2013

5. Low-level laser therapy (LLLT) acts as cAMP-elevating agent in acute respiratory distress syndrome;De Lima;Lasers Med. Sci.,2011

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using the sympathetic system, beta blockers and alpha-2 agonists, to address acute respiratory distress syndrome;International Immunopharmacology;2024-09

2. Photobiomodulation Treatment with a Home-Use Device for COVID-19: A Randomized Controlled Trial for Efficacy and Safety;Photobiomodulation, Photomedicine, and Laser Surgery;2024-06-01

3. Efficiency of exogenous surfactant combined with intravenous N-acetylcysteine in two-hit rodent model of ARDS;Respiratory Physiology & Neurobiology;2023-10

4. Use of either transcranial or whole‐body photobiomodulation treatments improves COVID‐19 brain fog;Journal of Biophotonics;2023-04-29

5. Can photobiomodulation restore anosmia and ageusia induced by COVID‐19? A pilot clinical study;Journal of Biophotonics;2023-03-22